BBC NEWS | Health | Row over NHS kidney drug decision
Patients with advanced kidney cancer will be denied four treatments on the NHS under proposals from the government's drugs advisory body.
The drugs - bevacizumab, sorafenib, sunitinib and temsirolimus - do not offer value for money, according to draft guidelines for England and Wales.
Thursday, August 7, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment